Why use V-Veil UP2TM self-sampling device for HPV&STIs Our patented technology releases all the biochemical molecules (DNA and proteins) contained in a woman’s genital secretion. V-Veil UP2TM is 15% to 20% more efficient than the flocked swab. Better release of genital secretion: If more is released, more lives we save! A clinical field research study* of 253 female participants, conducted by the European Hospital Pompidou (Paris), - using Seegene reagents - demonstrates that collecting female genital secretions using V-Veil UP2TM, a self-sampling device offered by V-Veil-UP Production, detects up to 2 times more HPV than the flocked swab. Improved detection performance for oncogenic HPVs: If more is detected, we save more lives! *Study published in scientific journals and medical congresses, available on the website hpv-veil.com Our patented, next-generation primary tube with “RetrofitterTM” allows laboratories to use the primary tube, containing the V-Veil UP2TM self-sampling device, directly in the automation, without the need for an intermediate tube and barcode. Direct use of the primary tube is optimal for HPV and STIs molecular testing. Ease of use in terms of automation: Faster and more economical! Reduced risk of pre-analytical error. V-Veil-UP2TM self-sampling device does not use transport fluid**, and can be stored up to 3 weeks at room’s temperature, after use. The system enables us to respond officialy to national HPV or STIs screening campaigns. Regulatory compliance for HPV & STIs testing campaigns. Neutrality with respect to molecular biology reagents used. Compatibility with all HPV PCR kits on the market. **In fact, it is strictly forbidden for the patient to use a collection tube with transport fluid, without the supervision of a professional. National Campaigns Laboratories V-Veil-Up Production SRL Romania [email protected] +40 348 42